Fuqua Professor David Ridley

Everything You Need to Know About FDA’s Priority Review Vouchers Worth $100’s of Millions.

Never Heard of These 'PRV's' but What a Potential Bonanza for the Recipients. They're transferable - as in they can be...

Ehave’s Mobile Ketamine Clinic, Rolling into Town.

Longer term, Ehave's (EHVVF) performance has been a quite a disappointment. Investors grew impatient for the launch...
ehave

Ehave, Inc. Announces its KetaDASH Mobile Unit Delivered to Miami Beach.

MIAMI, June 03, 2022 (GLOBE NEWSWIRE) — Ehave, Inc. (OTC Pink: EHVVF) (the “Company”), a leading healthcare services and technology company, announced...

Adding Progressive Care (RXMD) $0.04 to Watch List.

Adding to Biotech Stock Review 2022 Watch List. Speculative, Yes. But Pay Down of $2 Million Toxic Note and...

Can Lightning Strike Twice? Mitesco (MITI, MITID) Health Clinics.

Mitesco one of our Past Clients, Gained 10-Fold After we Added it to the Watch List, Just did a Reverse Split...

Video: New Topical Drug Delivery System, NeuroDirect™

Must Watch Video. Topical Application to Improve Delivery of FDA-Approved Drugs. https://youtu.be/2CGT7P9QEvo Can...

Latest article

GeoVax (GOVX) Provides First Half 2024 Business Update.

Award of BARDA Project NextGen contract represents a significant milestone event; Total value...

Reverse Split Mania! Solgenix (SNGX) Jumps 448% After 1:16.

Can You Imagine Selling Solgenix at $2.00 yesterday. And to be honest, news wasn't all that big - such...

Nine Page Summary Report on GeoVax (GOVX)

This is a great long-term story. We’re telling you. When we finished writing our earlier 44-page report,...